Skip to main content
Log in

Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results

  • Basic Research
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Injury to the spinal cord results in disruption of neurons, cell membranes, axons, myelin, and endothelial cells. The aim of this study was to demonstrate the protective effect of magnesium sulfate on the blood-spinal cord barrier after acute spinal cord injury (SCI). This experiment was conducted in two parts. In the first, rats were injected intravenously with Evans blue 2 h after SCI. The laminectomy-only group had no trauma. Contusion injury (50 g-cm) was applied to the trauma and treatment groups. Magnesium sulfate (600 mg/kg) was given to the treatment group immediately after injury. For the second part, clinical evaluations were performed 24 h post surgery. Then, following Evans blue injection, spinal cord samples were obtained from the laminectomy-only, trauma, and treatment groups. For the control group, nontraumatized spinal cord samples were taken after Evans blue injection following clinical examination. Laminectomy did not affect the spinal cord Evans blue content in 2-h and 24-h groups. The trauma increased tissue Evans blue content, and 24-h samples showed more remarkable tissue Evans blue content, suggesting secondary injury. Application of 600 mg/kg of magnesium resulted in lower Evans blue content in the spinal cord than with injury. Remarkable clinical neuroprotection was observed in the treatment groups. Magnesium sulfate showed vaso- and neuroprotective properties after contusion injury to the rat spinal cord. The authors also demonstrated secondary injury of the blood-spinal cord barrier with the Evans blue clearance technique for the first time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.

Similar content being viewed by others

References

  1. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, Dumont AS (2001) Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 24:254–264

    Article  CAS  PubMed  Google Scholar 

  2. Mautes AEM, Weinzierl MR, Donovan F, Noble LJ (2000) Vascular events after spinal cord injury. Phys Ther 80:673–687

    CAS  PubMed  Google Scholar 

  3. Tator CH, Fehlings MG (1991) Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75:15–26

    CAS  PubMed  Google Scholar 

  4. Hall ED, Wolf DL (1986) A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia. J Neurosurg 64:951–961

    CAS  PubMed  Google Scholar 

  5. Anthes DL, Theriault E, Tator CH (1996) Ultrastructural evidence for arterial vasospasm after spinal cord trauma. Neurosurgery 39:804–814

    CAS  PubMed  Google Scholar 

  6. Schlosshauer B (1993) The blood-brain barrier: morphology, molecules, and neurothelin. Bioassay 15:341–346

    CAS  Google Scholar 

  7. Heat DL, Vink R (1999) Optimization of magnesium therapy after severe diffuse axonal injury in rats. J Pharmacol Exper Ther 288:1311–1316

    Google Scholar 

  8. Lang-Lazdunski L, Hearteaux C, Dupont H, Widmann C, Lazdunski M (2000) Prevention of ischemic spinal cord injury: comparative effects of magnesium sulphate and riluzole. J Vasc Surg 32:179–189

    Article  CAS  Google Scholar 

  9. Robertson CS, Foltz R, Grossman G, Goodman JC (1986) Protection against experimental ischemic spinal cord injury. J Neurosurg 64:633–642

    CAS  PubMed  Google Scholar 

  10. Simpson JA, Eide TR, Schiff GA, Clagnaz JF, Hossain I, Tverskoy A, Koski G (1994) Intrathecal magnesium sulphate protects the spinal cord from ischemic injury during aortic cross-clamping. Anesthesiology 81:1493–1499

    CAS  PubMed  Google Scholar 

  11. Ustun ME, Gurbilek M, Ak A, Vatansev H, Duman A (2001) Effects of magnesium sulphate on tissue lactate and malondialdehyde levels in experimental head trauma. Intensive Care Med 27:264–268

    Article  CAS  PubMed  Google Scholar 

  12. Muir KW, Less KR (1995) A randomized, double blind, placebo controlled pilot trial of intravenous magnesium sulphate in acute stroke. Stroke 26:1183–1188

    CAS  PubMed  Google Scholar 

  13. Dickens BF, Weglicki WB, Li YS, Mak IT (1992) Magnesium deficiency in vitro enhances free radical induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 311:187–191

    Article  CAS  PubMed  Google Scholar 

  14. Delbarre B, Floyd RA, Delbarre G, Calinon F (1992) Glutamate accumulation and increased hydroxyl free radical formation in the abdominal aorta and heart of gerbil after ischemia/reperfusion insult. Free Rad Biol Med 13:31–34

    Article  CAS  PubMed  Google Scholar 

  15. Ram Z, Sadeh M, Shacked I, Sahar I, Hadani M (1991) Magnesium sulphate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 22:922–927

    CAS  PubMed  Google Scholar 

  16. Sadeh M (1989) Action of magnesium sulphate in the treatment of preeclampsia-eclampsia. Stroke 20:1273–1275

    CAS  PubMed  Google Scholar 

  17. Arakawa H, Kawikova I, Lofdahl CG, Lotval J (1992) Bradykinin-induced airway responses in guinea pig: effects of inhibition of cyclooxygenase and thromboxane synthetase. Eur J Pharmacol 229:131–136

    Article  CAS  PubMed  Google Scholar 

  18. Lehoux S, Plante GE, Sirois MG, Sirois P, D'Orleans-Juste P (1992) Phosphoramidon blocks big-endothelin-1 but not endothelin-1 enhancement of vascular permeability in the rat. Br J Pharmacol 107:996–1000

    CAS  PubMed  Google Scholar 

  19. Martin CAE, Advenier C (1993) Effects of cromacalim on bradykinin, histamine and substance P-induced airway microvascular leakage in the guinea pig. Eur J Pharmacol 239:119–126

    Article  CAS  PubMed  Google Scholar 

  20. Kashiwaguchi S, Masaki K, Ikata T (1989) Experimental studies on permeability of tracers into the spinal cord. Paraplegia 27:372–381

    CAS  PubMed  Google Scholar 

  21. Noble LJ, Maxwell DS (1983) Blood-spinal cord barrier response to transaction. Exp Neurol 79:188–199

    CAS  PubMed  Google Scholar 

  22. Orendacova J, Marsala M, Marsala J (1991) The blood-brain barrier permeability in graded postischemic spinal cord reoxygenation in rabbits. Neurosci Lett 28:143–146

    Article  Google Scholar 

  23. Wisselink W, Patetsios P, Panetta T, Ramirez JA, Rodino W, Kirwin JD, Zikra BA (1998) Medium molecular weight pentastarch reduces reperfusion injury by decreasing capillary leak in an animal model of spinal cord ischemia. J Vasc Surg 27:109–116

    CAS  PubMed  Google Scholar 

  24. Smith SL, Scherch HM, Hall ED (1996) Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury. J Neurosurg 84:229–233

    CAS  PubMed  Google Scholar 

  25. Allen AR (1911) Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. A preliminary report. JAMA 57:878–880

    Google Scholar 

  26. Rivlin AS, Tator CH (1978) Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 10:39–43

    Google Scholar 

  27. Basso DM, Beattie MS, Bresnahan JC (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244–256

    Article  CAS  Google Scholar 

  28. Gale K, Kerasidis H, Wrathall JR (1985) Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment. Exp Neurol 88:123–134

    CAS  PubMed  Google Scholar 

  29. Kaptanoglu E, Caner HH, Surucu SH, Akbiyik F (1999) Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury. J Neurosurg (Spine 2) 91:200–204

    Google Scholar 

  30. Anderson DK, Means ED, Waters TR (1980) Spinal cord energy metabolism in normal and postlaminectomy cats. J Neurosurg 52:387–391

    CAS  PubMed  Google Scholar 

  31. Anderson DK, Nicolosi GR, Means ED, Hartley E (1978) Effects of laminectomy on spinal cord blood flow. J Neurosurg 48:232–238

    CAS  PubMed  Google Scholar 

  32. Oliver CN, Starke-Reed PE, Stadtman ER, Liu GJ, Carney JM, Floyd RA (1990) Oxidative damage to brain proteins, loss of glutamate synthase activity, and production of free radicals during ischemia/reperfusion induced injury to gerbil brain. Proc Natl Acad Sci U S A 87:5144–5147

    CAS  PubMed  Google Scholar 

  33. Nadler JL, Goodson S, Rude RK (1987) Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 9:379–783

    CAS  PubMed  Google Scholar 

  34. Hubschmann OR, Nathanson DC (1985) The role of calcium and cellular membrane dysfunction in experimental trauma and subarachnoid hemorrhage. J Neurosurg 62:698–703

    CAS  PubMed  Google Scholar 

  35. Altura BT, Altura BM (1982) The role of magnesium in etiology of strokes and cerebrovasospasm. Magnesium 1:277–291

    Google Scholar 

  36. Miura K (1988) Changes in Mg++ concentration of CSF after subarachnoid hemorrhage and Mg++ effects on the contractions of bovine cerebral artery. No Shinkei Geka 16:1251–1259

    CAS  PubMed  Google Scholar 

  37. Rothman SM, Olney JW (1987) Excitotoxicity and the NMDA receptor. Trends Neurol Sci 10:299–302

    Article  CAS  Google Scholar 

  38. Suzer T, Coskun E, Islakel H, Tahta K (1999) Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury. Spinal Cord 37:480–484

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Etem Beskonakli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaptanoglu, E., Beskonakli, E., Solaroglu, I. et al. Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results. Neurosurg Rev 26, 283–287 (2003). https://doi.org/10.1007/s10143-003-0272-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-003-0272-y

Keywords

Navigation